Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
13 participants
INTERVENTIONAL
2025-06-02
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sites receiving external facilitation
Sites will receive guidance from an external facilitator to support uptake of the VRP.
External Facilitation
Designated external facilitators will conduct monthly meetings with local champions at each site. Designated facilitators will follow the developed facilitation guide, that includes content area to cover in each meeting, case scenarios as examples, and tips on how to communicate and support the internal facilitators. The goal is to enable problem-solving and support the local champion in implementing VRP with fidelity
Sites not receiving external facilitation
Sites will not receive guidance from an external facilitator.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
External Facilitation
Designated external facilitators will conduct monthly meetings with local champions at each site. Designated facilitators will follow the developed facilitation guide, that includes content area to cover in each meeting, case scenarios as examples, and tips on how to communicate and support the internal facilitators. The goal is to enable problem-solving and support the local champion in implementing VRP with fidelity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliated with Kaiser Permanente Northern California (KPNC) or Children's Hospital of Philadelphia Newborn Care Network (CNBCN)
* Recruited by study team
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agency for Healthcare Research and Quality (AHRQ)
FED
Children's Hospital of Philadelphia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sagori Mukhopadhyay
Principal Investigator, Attending Neonatologist, Associate Professor of Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sagori Mukhopadhyay, MD, MMSc
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital of Philadelphia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Permanente Modesto Medical Center
Modesto, California, United States
Kaiser Permanente East Bay - Oakland Medical Center
Oakland, California, United States
Kaiser Permanente Roseville Medical Center
Roseville, California, United States
Kaiser Permanente San Francisco Medical Center
San Francisco, California, United States
Kaiser Permanente San Leandro Medical Center
San Leandro, California, United States
Kaiser Permanente Santa Clara Medical Center
Santa Clara, California, United States
Kaiser Permanente Walnut Creek Medical Center
Walnut Creek, California, United States
Medical Center of Princeton
Plainsboro, New Jersey, United States
Virtua Voorhees
Voorhees Township, New Jersey, United States
Lancaster General Hospital
Lancaster, Pennsylvania, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Pennsylvania Hospital
Philadelphia, Pennsylvania, United States
Chester County Hospital
West Chester, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Dr. Michael W. Kuzniewicz
Role: primary
Dr. Michael W. Kuzniewicz
Role: primary
Dr. Michael W. Kuzniewicz
Role: primary
Dr. Michael W. Kuzniewicz
Role: primary
Dr. Michael W. Kuzniewicz
Role: primary
Dr. Michael W. Kuzniewicz
Role: primary
Dr. Michael W. Kuzniewicz
Role: primary
Dr. Sagori Mukhopadhyay
Role: primary
Dr. Sagori Mukhopadhyay
Role: primary
Dr. Sagori Mukhopadhyay
Role: primary
Dr. Sagori Mukhopdhyay
Role: primary
Dr. Sagori Mukhopadhyay
Role: primary
Dr. Sagori Mukhopadhyay
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GRT-00003877
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
24-021976
Identifier Type: -
Identifier Source: org_study_id